Ever Source Wealth Advisors, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.5 Billion
- Q2 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 21 shares of MDGL stock, worth $4,557. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 17
23.53%
Holding current value
$4,557
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MDGL
# of Institutions
297Shares Held
21.9MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$539 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$446 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$428 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$416 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$401 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $3.71B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...